| Name | GNF-6231 | 
|---|---|
| Synonyms | N-[5-(4-Acetyl-1-piperazinyl)-2-pyridinyl]-2-(2'-fluoro-3-methyl-2,4'-bipyridin-5-yl)acetamide [2,4'-Bipyridine]-5-acetamide, N-[5-(4-acetyl-1-piperazinyl)-2-pyridinyl]-2'-fluoro-3-methyl- | 
| Description | GNF-6231 is a potent, selective, and orally bioavailable Porcupine inhibitor that blocks Wnt signaling.1) GNF-6231 shows IC50s of greater than 10 μM on all CYP isoforms tested2) GNF-6231 have favorable potency and a PK profile across preclinical species upon oral administration.3) The reference for orally in MMTV-Wnt1 tumor bearing mice is dosed at 3 mg/kg.4) GNF-6231 showed very robust dose-related antitumor efficacy. | 
|---|---|
| Related Catalog | |
| References | 
| Density | 1.3±0.1 g/cm3 | 
|---|---|
| Boiling Point | 746.0±60.0 °C at 760 mmHg | 
| Molecular Formula | C24H25FN6O2 | 
| Molecular Weight | 448.493 | 
| Flash Point | 405.0±32.9 °C | 
| Exact Mass | 448.202301 | 
| LogP | 0.79 | 
| Vapour Pressure | 0.0±2.5 mmHg at 25°C | 
| Index of Refraction | 1.627 | 
| Storage condition | -20℃ |